文献速递中枢神经肿瘤放疗放疗物理与技术

在脑转移瘤立体定向放疗中,不均匀肿瘤剂量分布比均匀分布提供更好的局部控制

Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases.
PubMed 文献 · Radiother Oncol · 2018-07-17

该研究分析了2014至2017年在本机构接受分次立体定向放疗的134例新诊断脑转移瘤患者,比较不均匀与均匀剂量分布对局部控制和放射性坏死的影响;中位随访12.4个月后,不均匀组1年局部控制率和放射性坏死率分别为93%和0%,均匀组分别为78%和7.5%(p=0.005)。

要点

  • 不均匀剂量分布组1年局部控制率为93%,均匀分布组为78%(p=0.005)。
  • 不均匀剂量分布组1年放射性坏死率为0%,均匀分布组为7.5%。
  • 多因素分析显示局部控制改善与立体定向放疗剂量分布(p=0.009)和肿瘤体积(p=0.03)显著相关。

核心结论

  • 与均匀剂量分布相比,采用不均匀剂量分布的立体定向放疗获得了更好的局部控制和更低的放射性坏死风险。

研究设计与样本

  • 本研究为单机构分析,纳入2014年至2017年接受分次立体定向放疗的新诊断脑转移瘤患者134例(中位年龄61岁),其中114例脑转移瘤≤2个,20例为3-6个。
  • 治疗采用直线加速器容积旋转调强放疗。
  • 连续91例患者(脑转移瘤136个)接受均匀剂量分布照射,总剂量21-23.1 Gy分3次,要求99%的剂量覆盖99%的计划靶体积(第1组);随后43例患者(脑转移瘤72个)接受不均匀剂量照射,处方剂量10或11 Gy至等中心,70%等剂量线覆盖计划靶体积(第2组)。
  • 分析变量包括剂量分布、年龄、性别、组织学、诊断特异性分级预后评估评分、脑转移瘤数目、颅外转移 presence 和肿瘤体积。

主要发现

  • 中位随访12.4个月(范围1.4-33.1个月)后,第1组1年局部控制率为78%、放射性坏死率为7.5%,第2组分别为93%和0%(p=0.005)。
  • 多因素分析中,局部控制改善与立体定向放疗剂量分布(p=0.009)和肿瘤体积(p=0.03)显著相关。
  • 转移瘤数目(p=0.03)和立体定向放疗剂量分布(p=0.04)均与放射性坏死风险增加相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The aim of this study was to analyze the impact of inhomogeneous versus homogeneous dose distribution on local control (LC) and radionecrosis (RN) in patients treated with fractionated stereotactic radiotherapy (SRT) for newly-diagnosed brain metastases (BM). PATIENTS AND METHODS: From 2014 to 2017, 134 patients (median age 61 years) underwent SRT for BM (n = 114 with ≤2, n = 20 with 3-6 BM) at our institution. Treatment was delivered using volumetric modulated arc therapy on a linear accelerator. Ninety-one consecutive patients (BM = 136) were irradiated at a dose of 21-23.1 Gy in 3 fractions delivered homogeneously (99% of the dose had to cover 99% of the planning target volume (PTV)) (group 1) whereas the following 43 patients (BM = 72) received an inhomogeneous dose of 10 or 11 Gy prescribed to the isocenter with the 70% isodose line covering the PTV (group 2). Variables analyzed included dose distribution, age, gender, histology, diagnosis-specific Graded Prognostic Assessment score, number of brain metastases, presence of extracranial metastases, and tumor volumes. RESULTS: After a median follow-up of 12.4 months (range, 1.4-33.1), the 1-year LC and RN rate were 78% and 7.5% in group 1 and 93% and 0% in group 2, respectively (p = 0.005). In multivariate analysis, improved LC was significantly correlated with SRT dose distribution (p = 0.009) and tumor volume (p = 0.03). The number of metastases (p = 0.03) and SRT dose distribution (p = 0.04) were both associated with increased risk of RN. CONCLUSION: SRT delivered with inhomogeneous dose distribution resulted in better LC and a lower risk of RN compared to homogeneous distribution.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Lucia F, Key S, Dissaux G, et al. Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases. Radiother Oncol. 2018. PMID: 30017105. doi:10.1016/j.radonc.2018.06.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。